<--- Back to Details
First PageDocument Content
Cell biology / Thrombin / Coagulation / Protease-activated receptor / Apoptosis / Capillary / Biology / Coagulation system / Anatomy
Date: 2007-04-12 12:54:51
Cell biology
Thrombin
Coagulation
Protease-activated receptor
Apoptosis
Capillary
Biology
Coagulation system
Anatomy

I am an anesthesiologist from California. I have no conflict of interest and am sponsoring my own participation at this meeting. I believe that emerging theories can serve as guides to evaluate potential anesthetic toxic

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 51,54 KB

Share Document on Facebook

Similar Documents

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

DocID: 1riKA - View Document

Microsoft Wordfile00

Microsoft Wordfile00

DocID: 1r9dZ - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

RECOTHROM, Thrombin topical (Recombinant) Package Insert

RECOTHROM, Thrombin topical (Recombinant) Package Insert

DocID: 1qv5K - View Document

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

DocID: 1qk7W - View Document